July 19, 2021
Arcalis President Tomoyuki Fujisawa Arcalis, a CDMO specializing in mRNA-based therapeutics established in April in Chiba Prefecture, aims to grow its business to annual sales of several tens of billions of yen within several years. The company plans to build...read more